From January 1, 2024 to April 1, 2024, the company has repurchased 6,500,000 shares, representing 0.46% for CNY 39.94 million. With this, the company has completed the repurchase of 15,500,000 shares, representing 1.11% for CNY 100.01 million under the buyback announced on December 8, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 CNY | +0.15% | -1.36% | -1.51% |
Apr. 29 | Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 1.26B | |
+33.25% | 699B | |
+27.50% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.62% | 236B | |
+4.51% | 198B | |
-11.04% | 194B | |
-5.59% | 154B |
- Stock Market
- Equities
- 000650 Stock
- News Renhe Pharmacy Co., Ltd.
- Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.